Guidance on opioid tapering in the context of chronic pain: Evidence, practical advice and frequently asked questions

Laura Murphy; Roshina Babaei-Rad; Donna Buna; Pearl Isaac; Andrea Murphy; Karen Ng; Loren Regier; Naomi Steenhof; Maria Zhang; Beth Sproule

doi:10.1177/1715163518754918

Guidance on opioid tapering in the context of chronic pain: Evidence, practical advice and frequently asked questions

Can Pharm J (Ott). 2018 Feb 8;151(2):114-120. doi: 10.1177/1715163518754918. eCollection 2018 Mar-Apr.

Authors

Laura Murphy^{1

2

3

4

5

6

7}, Roshina Babaei-Rad^{1

2

3

4

5

6

7}, Donna Buna^{1

2

3

4

5

6

7}, Pearl Isaac^{1

2

3

4

5

6

7}, Andrea Murphy^{1

2

3

4

5

6

7}, Karen Ng^{1

2

3

4

5

6

7}, Loren Regier^{1

2

3

4

5

6

7}, Naomi Steenhof^{1

2

3

4

5

6

7}, Maria Zhang^{1

2

3

4

5

6

7}, Beth Sproule^{1

2

3

4

5

6

7}

Affiliations

¹ Toronto Rehab (L. Murphy, Steenhof), University Health Network, Toronto.
² Centre for Addiction and Mental Health (Babaei-Rad, Isaac, Zhang, Sproule), Toronto, Ontario.
³ Regional Pain Program (Buna), Victoria, British Columbia.
⁴ College of Pharmacy (A. Murphy), Dalhousie University, Halifax, Nova Scotia.
⁵ Toronto Academic Pain Medicine Institute (Ng), Women's College Hospital, Toronto, Ontario.
⁶ RxFiles Academic Detailing (Regier), Saskatoon Health Region, Saskatoon, Saskatchewan.
⁷ Leslie Dan Faculty of Pharmacy (Steenhof, Zhang, Sproule), University of Toronto, Toronto, Ontario.

No abstract available